Legal Suvidha is a registered trademark. Unauthorized use of our brand name or logo is strictly prohibited. All rights to this trademark are protected under Indian intellectual property laws.
Legal Suvidha
Back to Updates
LatestLicenses And Certifications 18 July 2026

News Updates

EMA accepts Eisai application for insomnia drug lemborexant, old vs new tax regime for AY 2026-27, India's retail female workers denied right to rest, government plans MSME reforms, DGFT launches online certificate of origin facility, and UP plans India's largest robotics hub in Noida, the government is taking various steps to improve the economy and the lives of its citizens, including the approval of new drugs, reforms in the tax regime, and the launch of new facilities for exporters, the government is also planning to improve the lives of retail female workers and is taking steps to improve liquidity and ease compliance for MSMEs

The European Medicines Agency (EMA) has accepted Eisai's application for the insomnia drug lemborexant.
In other news, taxpayers are considering which tax regime to choose for AY 2026-27, with the old tax regime having varying income tax slab rates based on age category, and the new tax regime having a more simplified structure.
- The government is planning to provide statutory backing to the Udyam registration portal to improve liquidity and ease compliance for MSMEs.
- The DGFT has launched an online certificate of origin facility for India-UK CETA exporters, which will make it easier for them to export goods.
- UP is planning to build India's largest robotics hub in Noida, which will focus on AI and deep tech, and aims to rule in these areas,
the government is also planning to improve the lives of retail female workers who are denied the right to rest, by providing them with better working conditions

Need help understanding this update?

Connect with our domain experts instantly via WhatsApp for customized legal guidance.

Chat on WhatsApp

* May contain AI generated content. Please verify the required details.